Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.

Labrador, J

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. [electronic resource] - Bone marrow transplantation May 2014 - 684-90 p. digital

Publication Type: Journal Article

1476-5365

10.1038/bmt.2014.17 doi


Adult
Aged
Drug Therapy, Combination
Female
Graft vs Host Disease--drug therapy
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Immunosuppressive Agents--administration & dosage
Incidence
Male
Methotrexate--administration & dosage
Middle Aged
Multivariate Analysis
Prognosis
Retrospective Studies
Risk Factors
Sirolimus--administration & dosage
Tacrolimus--administration & dosage
Thrombotic Microangiopathies--epidemiology
Transplantation, Homologous
Young Adult